Ιn a single-center, double-blinded, randomized placebo-controlled study, Hp eradication did not improve clinical outcomes in PD, suggesting no potential benefit from routine Hp-screening or Hp-eradication in the management of PD [114]. The gene discussed is HP; the disease is Parkinson disease.